DOI QR코드

DOI QR Code

Clinical Factors Related with Helicobacter Pylori Infection - Is there an Association with Gastric Cancer History in First-Degree Family Members?

  • Demirel, Busra B. ;
  • Akkas, Burcu Esen ;
  • Vural, Gulin Ucmak
  • Published : 2013.03.30

Abstract

Background: The aim of this study was to assess clinical factors associated with Helicobacter pylori positivity and to evaluate the incidence of gastric carcinoma in first-degree family members of infected patients. A total of 580 patients (mean age:$38{\pm}17$) with gastrointestinal complaints underwent C-14 urea breath test (UBT). Patients were grouped as: Group-1, untreated patients (n:384); and Group-2, patients who previously treated with eradication triple therapy (n:196). C-14 UBT was performed 1-2 months after the completion of eradication therapy. Associations of H pylori positivity with age, gender, ABO and Rhesus groups, smoking, dietary habits, and history of gastric cancer in first-degree family members were evaluated. The frequency of H pylori positivity was significantly higher in group-1 (58%) compared to group-2 (20%), p=0.001. There were no correlations between H pylori positivity and age, gender, ABO groups, Rhesus subgroups, smoking and dietary habits in both patient groups. The frequency of gastric cancer in family members was significantly higher in patients with H pylori infection among group-1, compared to infected patients among group-2 (56% vs. 28.6% respectively, p=0.03). We observed a significant association between H pylori positivity and the presence of gastric cancer in first-degree relatives of group-1 patients. Our results provide some confirmation of the presence of a link between gastric cancer development and H pylori. C-14 UBT is a sensitive, reliable and a widely recommended test for the detection of H pylori infection and recurrence. We suggest that detection and eradication of H pylori may contribute to a reduced risk of gastric cancer in the family members of infected patients.

Keywords

Helicobacter pylori;gastric cancer;C-14 urea breath test

References

  1. Ahuja V, Bal CS, Sharma MP (1998). Can the C-14 urea breath test replace follow-up endoscopic biopsies in patients treated for Helicobacter pylori infection? Clin Nucl Med, 23, 815-9. https://doi.org/10.1097/00003072-199812000-00005
  2. Aydin A, Ersoz G, Ozutemiz O, Tuncyurek M (2000). Low reinfection rate of Helicobacter pylori infection in Turkey. J Clin Gastroenterol, 30, 337.
  3. Blaser MJ, Perez-Perez GI, Kleanthous H, et al (1995). Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res, 55, 2111-5.
  4. Bohr UR, Annibale B, Franceschi F, Roccarina D, Gasbarrini A (2007). Extragastric manifestations of Helicobacter pylori infection -- other Helicobacters. Helicobacter, 12, 45-53.
  5. Borén T, Falk P, Roth KA, Larson G, Normark S (1993). Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science, 262, 1892-5. https://doi.org/10.1126/science.8018146
  6. Brenner H, Arndt V, Sturmer T, et al (2000). Individual and joint contribution of family history and Helicobacter pylori infection to the risk of gastric carcinoma. Cancer, 88, 274-9. https://doi.org/10.1002/(SICI)1097-0142(20000115)88:2<274::AID-CNCR5>3.0.CO;2-9
  7. Broutet N, Sarasqueta AM, Sakarovitch C, et al (2001). Helicobacter pylori infection in patients consulting gastroenterologists in France: prevalence is linked to gender and region of residence. Eur J Gastroenterol Hepatol, 13, 677-84. https://doi.org/10.1097/00042737-200106000-00011
  8. Correa P, Houghton J (2007). Carcinogenesis of Helicobacter pylori. Gastroenterology, 133, 659-72. https://doi.org/10.1053/j.gastro.2007.06.026
  9. Correa P, Piazuelo MB (2008). Natural history of Helicobacter pylori infection. Dig Liver Dis, 40, 490-6. https://doi.org/10.1016/j.dld.2008.02.035
  10. de Martel C, Parsonnet J (2006). Helicobacter pylori infection and gender: a meta-analysis of population-based prevalence surveys. Dig Dis Sci, 51, 2292-301. https://doi.org/10.1007/s10620-006-9210-5
  11. Desroches JJ, Lahaie RG, Picard M, et al (1997). Methodological validation and clinical usefulness of carbon-14-urea breath test for documentation of presence and eradication of Helicobacter pylori infection. J Nucl Med, 38, 1141-5.
  12. El-Omar EM, Carrington M, Chow WH, et al (2001). The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer. Nature, 412, 99.
  13. El-Omar EM, Rabkin CS, Gammon MD, et al (2003). Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology, 124, 1193-201. https://doi.org/10.1016/S0016-5085(03)00157-4
  14. Fuccio L, Zagari RM, Eusebi LH, et al (2009). Meta-analysis:can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Ann Intern Med, 151, 121-8. https://doi.org/10.7326/0003-4819-151-2-200907210-00009
  15. Gasparetto M, Pescarin M, Guariso G (2012). Helicobacter pylori eradication therapy: current availabilities. ISRN Gastroenterol,186734.
  16. Gisbert JP, Pajares JM (2004). 13C-urea breath test in the diagnosis of Helicobacter pylori infection -- a critical review. Aliment Pharmacol Ther, 20, 1001-17 https://doi.org/10.1111/j.1365-2036.2004.02203.x
  17. Graham DY, Malaty HM, Evans DG, et al (1991). Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. Gastroenterology, 100, 1495-501.
  18. Hishida A, Matsuo K, Goto Y, et al (2010). Smoking behavior and risk of Helicobacter pylori infection, gastric atrophy and gastric cancer in Japanese. Asian Pac J Cancer Prev, 11, 669-73.
  19. Kandulski A, Selgrad M, Malfertheiner P (2008). Helicobacter pylori infection: a clinical overview. Dig Liver Dis, 40, 619-26. https://doi.org/10.1016/j.dld.2008.02.026
  20. Kawasaki K, Kanemitsu K, Yasuda T, et al (2007). Family history of cancer in Japanese gastric cancer patients. Gastric Cancer, 10, 173-5. https://doi.org/10.1007/s10120-007-0427-6
  21. Kondo T, Toyoshima H, Tsuzuki Y, et al (2003). Aggregation of stomach cancer history in parents and offspring in comparison with other sites. Int J Epidemiol, 32, 579-83. https://doi.org/10.1093/ije/dyg152
  22. Loffeld RJ, Stobberingh E (1991). Helicobacter pylori and ABO blood groups. J Clin Pathol, 44, 516-7. https://doi.org/10.1136/jcp.44.6.516
  23. Malfertheiner P, Megraud F, O'Morain CA, et al (2012). Management of Helicobacter pylori infection--the maastricht IV/ Florence Consensus Report. Gut, 61, 646-64. https://doi.org/10.1136/gutjnl-2012-302084
  24. Megraud F (1993). Epidemiology of Helicobacter pylori infection. Gastroenterol Clin North Am, 22, 73-88.
  25. Mera R, Fontham ET, Bravo LE, et al (2005). Long term follow up of patients treated for Helicobacter pylori infection. Gut, 54, 1536-40. https://doi.org/10.1136/gut.2005.072009
  26. Moayyedi P, Axon AT, Feltbower R, et al (2002). Relation of adult lifestyle and socioeconomic factors to the prevalence of Helicobacter pylori infection. Int J Epidemiol, 31, 624-31. https://doi.org/10.1093/ije/31.3.624
  27. Niv Y, Fraser G, Delpre G, et al (1996). Helicobacter pylori infection and blood groups. Am J Gastroenterol, 91, 101-4.
  28. Parsonnet J, Friedman GD, Orentreich N, Vogelman H (1997). Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut, 40, 297-301. https://doi.org/10.1136/gut.40.3.297
  29. Peleteiro B, Lopes C, Figueiredo C, Lunet N (2011). Salt intake and gastric cancer risk according to Helicobacter pylori infection, smoking, tumour site and histological type. Br J Cancer, 104, 198-207. https://doi.org/10.1038/sj.bjc.6605993
  30. Queiroz DM, Silva CI, Goncalves MH, et al (2012). Higher frequency of cagA EPIYA-C phosphorylation sites in H pylori strains from first-degree relatives of gastric cancer patients. BMC Gastroenterol, 12, 107. https://doi.org/10.1186/1471-230X-12-107
  31. Rodrigues MN, Queiroz DM, Rodrigues RT, et al (2005). Helicobacter pylori infection in adults from a poor urban community in northeastern Brazil: demographic, lifestyle and environmental factors. Braz J Infect Dis, 9, 405-10. https://doi.org/10.1590/S1413-86702005000500008
  32. Salih BA, Abasiyanik MF, Ahmed N (2007). A preliminary study on the genetic profile of cag pathogenity-island and other virulent gene loci of Helicobacter pylori strains from Turkey. Infection, Genetics and Evolution, 7, 509-12. https://doi.org/10.1016/j.meegid.2007.03.002
  33. Sari YS, Can D, Tunali V, et al (2008). H pylori: Treatment for the patient only or the whole family? World J Gastroenterol, 14, 1244-7. https://doi.org/10.3748/wjg.14.1244
  34. Seyda T, Derya C, Fusun A, Meliha K (2007). The relationship of Helicobacter pylori positivity with age, sex, and ABO/Rhesus blood groups in patients with gastrointestinal complaints in Turkey. Helicobacter, 12, 244-50. https://doi.org/10.1111/j.1523-5378.2007.00500.x
  35. Sezikli M, Guliter S, Apan TZ, et al (2006). Frequencies of serum antibodies to helicobacter pylori CagA and VacA in a Turkish population with various gastroduedonal diseases. J Clin Pract, 60, 1239-43. https://doi.org/10.1111/j.1742-1241.2005.00778.x
  36. Sharara AI, Abdul-Baki H, ElHajj I, et al (2006). Association of gastroduodenal disease phenotype with ABO blood group and Helicobacter pylori virulence-specific serotypes. Dig Liver Dis, 38, 829-33. https://doi.org/10.1016/j.dld.2006.06.040
  37. Sitas F, Forman D, Yarnell JW, et al (1991). Helicobacter pylori infection rates in relation to age and social class in a population of Welsh men. Gut, 32, 25-8. https://doi.org/10.1136/gut.32.1.25
  38. Smith AW, Aathithan S, Power EG, Abdulla Y (1994). Blood group antigens and Helicobacter pylori infections. Lancet, 343, 543.
  39. Suzuki T, Matsuo K, Ito H, et al (2006). Smoking increases the treatment failure for Helicobacter pylori eradication. Am J Med, 119, 217-24. https://doi.org/10.1016/j.amjmed.2005.10.003
  40. Take S, Mizuno M, Ishiki K, et al (2005). The effect of eradicating helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease. Am J Gastroenterol, 100, 1037-42. https://doi.org/10.1111/j.1572-0241.2005.41384.x
  41. The EUROGAST Study Group (1993). Epidemiology of, and risk factors for, Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. Gut, 34, 1672-6. https://doi.org/10.1136/gut.34.12.1672
  42. Us D, Hascelik G (1998). Seroprevalence of Helicobacter pylori infection in an Asymptomatic Turkish population. J Infect, 37, 148-50. https://doi.org/10.1016/S0163-4453(98)80169-2
  43. Veldhuyzen van Zanten SJ, Sherman PM (1994). Helicobacter pylori infection as a cause of gastritis, duodenal ulcer, gastric cancer and nonulcer dyspepsia: a systematic overview. CMAJ, 150,177-85.
  44. Vieth M, Stolte M (2006). Elevated risk for gastric adenocarcinoma can be predicted from histomorphology. World J Gastroenterol, 12, 6109-14.
  45. Wang P, Zhang L, Jiang JM, et al (2012). Association of NOD1 and NOD2 genes polymorphisms with Helicobacter pylori related gastric cancer in a Chinese population. World J Gastroenterol, 18, 2112-20. https://doi.org/10.3748/wjg.v18.i17.2112
  46. Wu TC, Chen LK, Hwang SJ (2003). Seroprevalence of Helicobacter pylori in school-aged Chinese in Taipei City and relationship between ABO blood groups. World J Gastroenterol, 9, 1752-5.
  47. Zhang LH, Li Q, Li P, et al (2012). Association between gastric cancer and -1993 polymorphism of TBX21 gene. World J Gastroenterol, 18, 1117-22. https://doi.org/10.3748/wjg.v18.i10.1117

Cited by

  1. Prevalence and Risk Factors of H. pylori from Dyspeptic Patients in Northwest Ethiopia: A Hospital Based Cross-sectional Study vol.15, pp.11, 2014, https://doi.org/10.7314/APJCP.2014.15.11.4459
  2. Effect of Eradication of Helicobacter pylori on Expression Levels of FHIT, IL-8 and P73 in Gastric Mucosa of First-Degree Relatives of Gastric Cancer Patients vol.10, pp.4, 2015, https://doi.org/10.1371/journal.pone.0124576
  3. High Efficacy of Levofloxacin-Dexlansoprazole-Based Quadruple Therapy as a First Line Treatment for Helicobacter pylori Eradication in Thailand vol.16, pp.10, 2015, https://doi.org/10.7314/APJCP.2015.16.10.4353
  4. Seven-Day Bismuth-based Quadruple Therapy as an Initial Treatment for Helicobacter pylori Infection in a High Metronidazole Resistant Area vol.16, pp.14, 2015, https://doi.org/10.7314/APJCP.2015.16.14.6089
  5. Upper Gastrointestinal Tract Polyps: What Do We Know About Them? vol.16, pp.7, 2015, https://doi.org/10.7314/APJCP.2015.16.7.2999
  6. Effect of IL-1 Polymorphisms, CYP2C19 Genotype and Antibiotic Resistance on Helicobacter pylori Eradication Comparing Between 10-day Sequential Therapy and 14-day Standard Triple Therapy with Four-Times-Daily-Dosing of Amoxicillin in Thailand: a Prospective Randomized Study vol.17, pp.4, 2016, https://doi.org/10.7314/APJCP.2016.17.4.1903
  7. Equivalent Helicobacter pylori infection rates in Lynch syndrome mutation carriers with and without a first-degree relative with gastric cancer vol.31, pp.3, 2016, https://doi.org/10.1007/s00384-016-2524-7
  8. Adhesion and Invasion of Gastric Mucosa Epithelial Cells by Helicobacter pylori vol.6, pp.2235-2988, 2016, https://doi.org/10.3389/fcimb.2016.00159
  9. Infection on the Risk of Gastric Cancer in Chinese Individuals vol.18, pp.9, 2014, https://doi.org/10.1089/gtmb.2014.0047